Neurofibroma is a rare nerve sheath tumor of neuroectodermal origin, especially the huge and isolated neurofibroma located in the inguinal region. To our knowledge, no such case has previously been ...

Panelists discuss how MEK inhibitors, such as trametinib and selumetinib, are emerging as first-line treatments for symptomatic NF1-associated plexiform neurofibromas, especially in progressive or ...

A 15-year-old living with Neurofibromatosis has completed the first phase of surgery, with the Mogale City Business Committee NPC continuing to support him and his family.

This month, our discussion focuses on the clinical management of plexiform neurofibromas in the era of selumetinib, a MEK inhibitor medication that was approved by the FDA in 2020 for the treatment of ...

Fifteen-year-old Mahlatse Marema is recovering well after the first phase of surgery to relieve his Neurofibromatosis, with a local non-profit organisation by his side.

I am writing this towards the end of August (2023) and would like to use this occasion to recognize a milestone: the 40th anniversary of my involvement in neurofibromatosis. On August 11, 1983, I sent ...

CAMBRIDGE, England--(BUSINESS WIRE)--Healx, an AI-enabled, clinical-stage biotech company dedicated to rare diseases, today announced the first patient has been dosed in INSPIRE-NF1, a Phase 2 trial ...